Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 6
2003 7
2004 10
2005 16
2006 21
2007 17
2008 29
2009 22
2010 59
2011 62
2012 79
2013 85
2014 106
2015 135
2016 131
2017 153
2018 181
2019 204
2020 244
2021 303
2022 340
2023 289
2024 78

Text availability

Article attribute

Article type

Publication date

Search Results

2,301 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: sun t. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Antibody targeting of E3 ubiquitin ligases for receptor degradation.
Marei H, Tsai WK, Kee YS, Ruiz K, He J, Cox C, Sun T, Penikalapati S, Dwivedi P, Choi M, Kan D, Saenz-Lopez P, Dorighi K, Zhang P, Kschonsak YT, Kljavin N, Amin D, Kim I, Mancini AG, Nguyen T, Wang C, Janezic E, Doan A, Mai E, Xi H, Gu C, Heinlein M, Biehs B, Wu J, Lehoux I, Harris S, Comps-Agrar L, Seshasayee D, de Sauvage FJ, Grimmer M, Li J, Agard NJ, de Sousa E Melo F. Marei H, et al. Among authors: sun t. Nature. 2022 Oct;610(7930):182-189. doi: 10.1038/s41586-022-05235-6. Epub 2022 Sep 21. Nature. 2022. PMID: 36131013 Free PMC article.
RNA editing underlies genetic risk of common inflammatory diseases.
Li Q, Gloudemans MJ, Geisinger JM, Fan B, Aguet F, Sun T, Ramaswami G, Li YI, Ma JB, Pritchard JK, Montgomery SB, Li JB. Li Q, et al. Among authors: sun t. Nature. 2022 Aug;608(7923):569-577. doi: 10.1038/s41586-022-05052-x. Epub 2022 Aug 3. Nature. 2022. PMID: 35922514 Free PMC article.
Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: A blinded randomized controlled trial.
Zhou L, Qiu W, Wang J, Zhao A, Zhou C, Sun T, Xiong Z, Cao P, Shen W, Chen J, Lai X, Zhao LH, Wu Y, Li M, Qiu F, Yu Y, Xu ZZ, Zhou H, Jia W, Liao Y, Retnakaran R, Krewski D, Wen SW, Clemente JC, Chen T, Xie RH, He Y. Zhou L, et al. Among authors: sun t. Cell Host Microbe. 2023 Jul 12;31(7):1232-1247.e5. doi: 10.1016/j.chom.2023.05.022. Epub 2023 Jun 15. Cell Host Microbe. 2023. PMID: 37327780 Clinical Trial.
Bioinformatics analysis of ferroptosis in spinal cord injury.
Li JZ, Fan BY, Sun T, Wang XX, Li JJ, Zhang JP, Gu GJ, Shen WY, Liu DR, Wei ZJ, Feng SQ. Li JZ, et al. Among authors: sun t. Neural Regen Res. 2023 Mar;18(3):626-633. doi: 10.4103/1673-5374.350209. Neural Regen Res. 2023. PMID: 36018187 Free PMC article.
The enormous repetitive Antarctic krill genome reveals environmental adaptations and population insights.
Shao C, Sun S, Liu K, Wang J, Li S, Liu Q, Deagle BE, Seim I, Biscontin A, Wang Q, Liu X, Kawaguchi S, Liu Y, Jarman S, Wang Y, Wang HY, Huang G, Hu J, Feng B, De Pittà C, Liu S, Wang R, Ma K, Ying Y, Sales G, Sun T, Wang X, Zhang Y, Zhao Y, Pan S, Hao X, Wang Y, Xu J, Yue B, Sun Y, Zhang H, Xu M, Liu Y, Jia X, Zhu J, Liu S, Ruan J, Zhang G, Yang H, Xu X, Wang J, Zhao X, Meyer B, Fan G. Shao C, et al. Among authors: sun t. Cell. 2023 Mar 16;186(6):1279-1294.e19. doi: 10.1016/j.cell.2023.02.005. Epub 2023 Mar 2. Cell. 2023. PMID: 36868220 Free article.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: sun t. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
2,301 results